Clinical Trials Directory

Trials / Completed

CompletedNCT02768493

Ultrasonographic Assessment of Optic Nerve Sheath Diameter in Children Receiving Caudal Block

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
80 (actual)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
6 Months – 4 Years
Healthy volunteers
Not accepted

Summary

The recent study revealed that high-volume caudal block caused reduction in cerebral blood flow velocity and cerebral oxygenation. It was supposed to be associated with increased intracranial pressure. Ultrasonography of optic nerve sheath diameter shows a good level of diagnostic accuracy for detecting intracranial hypertension. The aim of this study is to evaluate the effect of caudal block on intracranial pressure in pediatric patients undergoing urologic surgery. Eighty patients, aged 6 months to 4 years, receiving caudal block before urologic surgery will be divided into high dose group (n=40) and low dose group (n=40). Randomly selected patients of the high dose group are given 1.5 ml/kg of 0.15% ropivacaine for caudal block. In contrast, patients in the low dose group are given 1.0 ml/kg of 0.15% ropivacaine for caudal block. The primary endpoint is the optic nerve sheath diameter after caudal block measured by optic nerve ultrasonography.

Conditions

Interventions

TypeNameDescription
DRUG1.0 ml/kg of 0.15% ropivacaineRandomly selected patients of the high dose group are given 1.5 ml/kg of 0.15% ropivacaine for caudal block before their surgery. In contrast, patients in the low dose group are given 1.0 ml/kg of 0.15% ropivacaine for caudal block before surgery.
DRUG1.5 ml/kg of 0.15% ropivacaineRandomly selected patients of the high dose group are given 1.5 ml/kg of 0.15% ropivacaine for caudal block before their surgery. In contrast, patients in the low dose group are given 1.0 ml/kg of 0.15% ropivacaine for caudal block before surgery.

Timeline

Start date
2016-05-01
Primary completion
2016-08-01
Completion
2016-08-01
First posted
2016-05-11
Last updated
2016-09-09

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT02768493. Inclusion in this directory is not an endorsement.